0 NYSE Companies - May 31, 2024Btab Ecommerce Group Signs Business Combination Agreement with Integrated Wellness Acquisition Corp.SYDNEY, Australia and New York, NY, May 31, 2024 (GLOBE NEWSWIRE) — Btab Ecommerce Group, Inc., an e-commerce company (OTC: […]Read More
0 TSX Venture News - May 31, 2024Robex Reports Operational and Financial Results for Q1 2024QUEBEC CITY, May 31, 2024 (GLOBE NEWSWIRE) — Robex Resources Inc. (“Robex” or the “Company“) (TSXV: RBX) today reports operational […]Read More
0 NYSE Companies - May 31, 2024Apollo to Present at the TD Financial Services & Fintech SummitNEW YORK, May 31, 2024 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) and Athene Holding Ltd. (“Athene”) today announced that Grant […]Read More
0 NYSE Companies - May 31, 2024Safe Bulkers, Inc. Announces the Implementation of Integrated Management System in Compliance with DryBMS StandardsMONACO, May 31, 2024 (GLOBE NEWSWIRE) — Safe Bulkers, Inc. (the Company) (NYSE: SB), an international provider of marine drybulk […]Read More
0 TSX Venture News - May 31, 2024Current Water Announces First Quarter 2024 Financial ResultsGUELPH, Ontario, May 31, 2024 (GLOBE NEWSWIRE) — Current Water Technologies Inc. (TSX-V: WATR) (“CWTI” or “the Company” or “the Corporation“), […]Read More
0 NASDAQ Companies - May 31, 2024Fundamental Global Inc. and Strong Global Entertainment, Inc. Enter Into Definitive Plan of ArrangementMooresville, NC, May 31, 2024 (GLOBE NEWSWIRE) — Subsidiaries of Fundamental Global Inc. (Nasdaq: FGF, FGFPP) (the “Company” or “Fundamental Global”) […]Read More
0 TSX Venture News - May 31, 2024Torr Metals Inc. (TSX.V: TMET) Featured in Syndicated Broadcast Covering Significant Increase in Sizing of Kolos Copper-Gold ProjectLOS ANGELES, May 31, 2024 (GLOBE NEWSWIRE) — via IBN — Torr Metals Inc. (TSX.V: TMET), a Canada-based company focused […]Read More
0 NASDAQ Companies - May 31, 2024Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic AtrophyEstablished Medium Dose as Safe and Tolerable Dose in Current OCU410 Clinical Trial DSMB Recommends Continuing with High-Dose Cohort Dosing […]Read More